China Tracker - Details for Tongli Pharmaceuticals (TGLP)

 Tongli Pharmaceuticals
Shares Outstanding (MRQ): 11.65 mill
New Shares / Dilution (TTM): 1.42 mill13.88% 
Cash (MRQ): 0.68 mill146.66%
Account Receivables (MRQ): 0.80 mill171.58%
Account Receivables (Q/Q): + 0.08 mill11.85% 
Long-Term Debt (MRQ): NO DEBT
Revenue Growth (Q/Q): -32.58% 
Revenue Growth (Y/Y): 296.58%
Net Income Growth (Q/Q): -63.11% 
Net Income Growth (Y/Y): N/A (BACK TO PROFITABILITY)
EPS Growth (Y/Y): N/A (BACK TO PROFITABILITY)
Net Margin (Q/Q): 16.0% (29.2%)-13.20% 
Net Margin (Y/Y): 16.0% (-2.0%)18.00% 
EPS | P/E (2 MRQ Projection): $0.220.18
CFPS | P/CF (2 MRQ Projection): $0.100.40
Price/Sales (2 MRQ Projection): 0.04
Price/Book (MRQ): 0.04
Auditor: Paritz & Company
 
 Forward Projections (Fiscal Year)
EPS | P/E (Estimates updated 2010-10-31): $0.150.27
 Basic Facts and History (show more)
Reporting Type: U.S. Company (10-K Filings) 
Going Public: Reverse Merger on 2008-08-12 

TGLP
Healthcare & Drugs
SCORE
14
READ: Score Cards Explained
SAFETY/RISK SCORE
HIGH RISK
DETAILS: Safety/Risk Model for TGLP
Current Price:  $0.04
F10k Day (2010-06-02): -93.85%$0.65
2010 Close: -95.51%$0.89
2011 Close: -86.67%$0.30
High (2012-03-20): -95.56%$0.90
Low (2012-02-08): 300.00%$0.01
Exchange: PNK
Market Capitalization: 0.47 mill
Total Shares: 11.65 mill
Float: n/a
Avg Volume: n/a
Last Quarter: 2010-09-30
Revenue (MRQ): 2.17 mill
Net Income (MRQ): 0.35 mill
Op. Cash Flow (MRQ): 0.56 mill
all financial data provided without warranty